What extra considerations are required for successfully implementing Decentralized Clinical Trials (DCTs) in addition to those for traditional site-based trials?
In this interview, Estelle Haenel, Chief Medical Officer at Kayentis, shares valuable insights on how to select a DCT strategy and ensure that DCTs remain patient-focused.
Check out the “Clinical Trial Chronicles” podcast on Spotify for more insights on clinical trials!
